126: 177
177: 28
138: 106
123: 62
153: 87
120: 74
15: 240
156: 77
129: 42
114: 101
186: 26
168: 86
171: 95
165: 88
117: 10
174: 44
180: 21
144: 6
135: 47
132: 21
147: 33
150: 24
189: 6
159: 23
225: 1
243: 1
210: 1
228: 1
288: 1
24: 1
63: 9
294: 1
evidence@of@vaccine@efficacy@starts@about@two@week@after@the@first@dose@high@efficacy@is@achieved@with@full@immunization@two@weeks@after@the@second@dose@and@was@evaluated@at@ninety@four@percent@after@the@vaccine@study@that@led@to@emergency@authorization@in@the@usa@there@were@eleven@cases@of@covid@in@the@vaccine@group@versus@a@hundred@and@eighty@five@cases@in@the@placebo@group@moreover@there@were@zero@cases@of@severe@sickness@in@the@vaccine@group@versus@eleven@in@the@placebo@group@this@efficacy@has@been@described@as@amazing@for@a@respiratory@virus@vaccine@and@it@is@similar@to@the@efficacy@in@the@biontech@vaccine@efficacy@estimates@were@similar@across@age@groups@genders@racial@and@ethnic@groups@plus@participants@with@medical@comorbidities@associated@with@high@risk@of@severe@covid@only@individuals@aged@eighteen@or@older@were@studied@studies@are@underway@to@gauge@efficacy@and@safety@in@children@a@further@study@conducted@under@the@cdc@between@december@and@march@on@almost@four@thousand@health@care@personnel@first@responders@and@other@essential@workers@concluded@that@under@real@world@conditions@mrna@vaccine@effectiveness@of@full@immunization@days@or@more@after@second@dose@was@ninety@percent@against@infections@regardless@of@symptoms@and@vaccine@effectiveness@of@partial@immunization@was@eighty@percent@the@duration@of@protection@provided@by@the@vaccine@is@unclear@as@of@april@this@year@and@a@two@year@followup@study@is@underway@to@determine@this@a@key@ingredient@in@the@vaccine@is@uufruuCtromethaminehydrochloridePPPPPPPPP
